丹诺医药IPO招股,“全球首个”新药有望年底获批|港股打新

21世纪经济报道
May 17

5月16日,丹诺医药开启招股第三天。据Wind数据,丹诺医药将成为2026年以来,继精锋医疗、博瑞生物、德适、迈威生物、英派药业之后,第6家按港交所上市规则第18A章在港挂牌的生物科技公司。  丹诺医药-B(06872.HK)  公司行业:制药  公司简介:丹诺医药成立于2013年,专注于细菌感染及细菌代谢相关疾病领域的创新药研发。目前,丹诺医药已建立由七项候选药物组成的管线,聚焦尚无或缺乏治疗...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10